170 related articles for article (PubMed ID: 1517921)
1. Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia.
Pearson E; Bose C; Snidow T; Ransom L; Young T; Bose G; Stiles A
J Pediatr; 1992 Sep; 121(3):420-7. PubMed ID: 1517921
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia.
Shenai JP; Kennedy KA; Chytil F; Stahlman MT
J Pediatr; 1987 Aug; 111(2):269-77. PubMed ID: 3302193
[TBL] [Abstract][Full Text] [Related]
3. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
Meyer S; Gortner L;
Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
[TBL] [Abstract][Full Text] [Related]
4. Plasma retinol-binding protein response to vitamin A administration in infants susceptible to bronchopulmonary dysplasia.
Shenai JP; Rush MG; Stahlman MT; Chytil F
J Pediatr; 1990 Apr; 116(4):607-14. PubMed ID: 2108233
[TBL] [Abstract][Full Text] [Related]
5. Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
Meyer S; Bay J; Franz AR; Ehrhardt H; Klein L; Petzinger J; Binder C; Kirschenhofer S; Stein A; Hüning B; Heep A; Cloppenburg E; Muyimbwa J; Ott T; Sandkötter J; Teig N; Wiegand S; Schroth M; Kick A; Wurm D; Gebauer C; Linnemann K; Kittel J; Wieg C; Kiechl-Kohlendorfer U; Schmidt S; Böttger R; Thomas W; Brevis Nunez F; Stockmann A; Kriebel T; Müller A; Klotz D; Morhart P; Nohr D; Biesalski HK; Giannopoulou EZ; Hilt S; Poryo M; Wagenpfeil S; Haiden N; Ruckes C; Ehrlich A; Gortner L;
Lancet Respir Med; 2024 Jul; 12(7):544-555. PubMed ID: 38643780
[TBL] [Abstract][Full Text] [Related]
6. Early vs delayed vitamin A supplementation in very-low-birth-weight infants.
Robbins ST; Fletcher AB
JPEN J Parenter Enteral Nutr; 1993; 17(3):220-5. PubMed ID: 8505826
[TBL] [Abstract][Full Text] [Related]
7. Vitamin A deficiency and severe bronchopulmonary dysplasia in very low birthweight infants.
Verma RP; McCulloch KM; Worrell L; Vidyasagar D
Am J Perinatol; 1996 Oct; 13(7):389-93. PubMed ID: 8960606
[TBL] [Abstract][Full Text] [Related]
8. Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very-low-birth-weight premature Thai infants: a randomized trial.
Kiatchoosakun P; Jirapradittha J; Panthongviriyakul MC; Khampitak T; Yongvanit P; Boonsiri P
J Med Assoc Thai; 2014 Oct; 97 Suppl 10():S82-8. PubMed ID: 25816542
[TBL] [Abstract][Full Text] [Related]
9. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.
Rakshasbhuvankar A; Patole S; Simmer K; Pillow JJ
BMC Pediatr; 2017 Dec; 17(1):204. PubMed ID: 29246130
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
[TBL] [Abstract][Full Text] [Related]
11. Effect of vitamin A supplementation on morbidity of low-birth-weight neonates.
Coutsoudis A; Adhikari M; Pillay K; Kuhn L; Coovadia HM
S Afr Med J; 2000 Jul; 90(7):730-6. PubMed ID: 10985138
[TBL] [Abstract][Full Text] [Related]
12. Sequential evaluation of plasma retinol-binding protein response to vitamin A administration in very-low-birth-weight neonates.
Shenai JP; Rush MG; Parker RA; Chytil F
Biochem Mol Med; 1995 Feb; 54(1):67-74. PubMed ID: 7551819
[TBL] [Abstract][Full Text] [Related]
13. Vitamin A supplementation in premature neonates with postnatal lung injury. Italian Collaborative Group on Preterm Delivery (ICGPD).
Int J Clin Pharmacol Ther; 1996 Aug; 34(8):362-5. PubMed ID: 8864801
[TBL] [Abstract][Full Text] [Related]
14. Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight.
Watts JL; Milner R; Zipursky A; Paes B; Ling E; Gill G; Fletcher B; Rand C
Eur Respir J; 1991 Feb; 4(2):188-90. PubMed ID: 2044736
[TBL] [Abstract][Full Text] [Related]
15. Oral vitamin A supplementation in very low birth weight neonates: a randomized controlled trial.
Basu S; Khanna P; Srivastava R; Kumar A
Eur J Pediatr; 2019 Aug; 178(8):1255-1265. PubMed ID: 31209560
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
Ballard HO; Anstead MI; Shook LA
Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
[TBL] [Abstract][Full Text] [Related]
17. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants.
Darlow BA; Graham PJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD000501. PubMed ID: 17943744
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A Supplementation for Prevention of Bronchopulmonary Dysplasia: Cornerstone of Care or Futile Therapy?
Gawronski CA; Gawronski KM
Ann Pharmacother; 2016 Aug; 50(8):680-4. PubMed ID: 27147702
[TBL] [Abstract][Full Text] [Related]
19. Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.
Gadhia MM; Cutter GR; Abman SH; Kinsella JP
J Pediatr; 2014 Apr; 164(4):744-8. PubMed ID: 24388327
[TBL] [Abstract][Full Text] [Related]
20. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
